Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 310 followers
Latest posts
Last updated 3 days ago
Veterinary medicines European public assessment report (EPAR): Emepax, maropitant, Status: Opinion
3 days ago
Veterinary medicines European public assessment report (EPAR): Emepax, maropitant, Status: Opinion
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 February 2026
3 days ago
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 February...
Summary of opinion: Suvaxyn PRRS MLV, 12/02/2026 Positive
3 days ago
Summary of opinion: Suvaxyn PRRS MLV, 12/02/2026 Positive
Summary of opinion: Bluevac BTV (previously Bluevac BTV8), 12/02/2026 Positive
3 days ago
Summary of opinion: Bluevac BTV (previously Bluevac BTV8), 12/02/2026 Positive
Concept paper for the revision of the guideline on veterinary good pharmacovigilance practices (VGVP) Module: Signal Management (EMA/522332/2021)
3 days ago
Concept paper for the revision of the guideline on veterinary good pharmacovigilance...
Highlights - 6th EMA-AESGP bilateral meeting
3 days ago
Highlights - 6th EMA-AESGP bilateral meeting
Medicinal products for human use: monthly figures - January 2026
3 days ago
Medicinal products for human use: monthly figures - January 2026
Human medicines European public assessment report (EPAR): Emtricitabine / Rilpivirine / Tenofovir Alafenamide Viatris, emtricitabine,rilpivirine,tenofovir alafenamide, Date of authorisation: 19/08/2025, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Emtricitabine / Rilpivirine / Tenofovir...
EMA recommends withdrawal of marketing authorisations for levamisole medicines
3 days ago
EMA recommends withdrawal of marketing authorisations for levamisole medicines
Referral: Levamisole-containing medicinal products, levamisole, associated names: Decaris,Levamisol Arena Article 31 referrals Recommendation provided by Pharmacovigilance Risk Assessment Committee, 13/02/2026
3 days ago
Referral: Levamisole-containing medicinal products, levamisole, associated names: Decaris,Levamisol Arena Article 31 referrals...
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9 - 12 February 2026
3 days ago
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9 - 12...